SeaStar Medical Holding Corporation Common StockICU

SeaStar Medical is a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss of life. SeaStar Medical's first commercial product, QUELIMMUNE® (SCD-PED), was approved in 2024 by the U.S. Food and Drug Administration.

seastarmedical.com